3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leukemia, Myeloid, Acute
45
Breast Neoplasms
20
Myelodysplastic Syndromes
19
Prostatic Neoplasms
12
Neoplasms
12
Leukemia, Myelomonocytic, Chronic
12
Carcinoma, Hepatocellular
10
Stomach Neoplasms
9
Recurrence
9
Carcinoma, Non-Small-Cell Lung
8
Neoplasm Metastasis
7
Esophageal Neoplasms
7
Uterine Cervical Neoplasms
6
Sarcoma
6
Ovarian Neoplasms
6
Multiple Myeloma
6
Lung Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myeloproliferative Disorders
5
Melanoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma, B-Cell
5
Esophageal Squamous Cell Carcinoma
5
Colorectal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Myelodysplastic-Myeloproliferative Diseases
4
Leukemia, Biphenotypic, Acute
4
Cholangiocarcinoma
4
Thrombocythemia, Essential
3
Interventions
Etoposide
10
Cisplatin
9
Cyclophosphamide
7
etoposide phosphate
5
Paclitaxel
5
Ifosfamide
5
Granulocyte Colony-Stimulating Factor
5
Carboplatin
5
fludarabine
4
Sirolimus
4
Gemcitabine
4
pembrolizumab
3
fludarabine phosphate
3
Sunitinib
3
Mesna
3
Melphalan
3
Filgrastim
3
Drug Therapy
3
Brentuximab Vedotin
3
Bleomycin
3
Bevacizumab
3
Automobiles
3
tremelimumab
2
sodium thiosulfate
2
pegfilgrastim
2
lutetium Lu 177 dotatate
2
durvalumab
2
Vorinostat
2
Stem Cell Transplantation
2
Oxaliplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Germ Cell and Embryonal
×
Injections
×
Clear all
NCT02582697
2025-06-15
P3BEP
University of Sydney
Phase 3
Recruiting
500 enrolled